MedPath

Stress Reduction Techniques and Anxiety: Therapeutic and Neuroendocrine Effects

Phase 4
Completed
Conditions
Generalized Anxiety Disorder
Interventions
Behavioral: Mindfulness Based Stress Reduction
Behavioral: Stress Management Education
Registration Number
NCT01033851
Lead Sponsor
Massachusetts General Hospital
Brief Summary

Current therapies for Generalized Anxiety Disorder (GAD) have limited effectiveness. This study measures the efficacy of two different approaches to reducing anxiety and stress. One approach uses education, nutrition, exercise, and time management training, and another uses mindfulness meditation and yoga, which is taught as part of the Mindfulness-based stress reduction (MBSR) course, an 8-week manualized mindfulness intervention. We hypothesize that the two approaches will reduce anxiety in individuals with GAD in different ways. We will measure changes in stress hormones associated with these changes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
89
Inclusion Criteria
  • Adults with generalized anxiety disorder
  • medically healthy
Exclusion Criteria
  • substance abuse
  • history of other psychiatric diagnoses such as psychosis, Obsessive Compulsive Disorder, PTSD
  • use of certain types of psychotherapy, meditation training, yoga
  • pregnant or lactating women

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mindfulness Based Stress ReductionMindfulness Based Stress ReductionMindfulness Based Stress Reduction (MBSR) is an 8-week group intervention that trains participants in mindfulness meditation techniques.
Stress Management EducationStress Management EducationStress Management Education (SME) is an 8-week group intervention that educates participants about stress physiology and health lifestyle changes.
Primary Outcome Measures
NameTimeMethod
Active Symptoms of Generalized Anxiety Disorder2 months

The Hamilton Anxiety Scale (HAMA) was defined as the primary anxiety outcome variable. This scale has 14 items describing symptoms of anxiety, each answered on a 0-4 scale, with 0 for a single question generally representing no symptoms, and 4 representing severe levels of the symptom. The total score is calculated by adding all the items together, for a possible total score of 0 to 56.

Secondary Outcome Measures
NameTimeMethod
Clinical Global Impression of Severity (CGIS) of Anxiety Symptoms.2 months

This is an overal clinical measure of anxiety symptoms after examining and interviewing the patient. The scale is one global item, that scores from 1 (1= not ill at all) to 7 (7= among the most extremely ill).

Trial Locations

Locations (1)

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath